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Background: There are no reported long-term data on amputation-free survival (AFS) and major adverse limb event with perioperative death 
(MALE+POD) as efficacy endpoints of endovascular treatment (EVT) for patients with critical limb ischemia (CLI) due to isolated below-the-knee 
(BTK) lesions. Therefore, we investigated long-term rates and factors associated with AFS and MALE+POD after EVT in this setting.
Methods: Between March 2004 and October 2010, 465 limbs (Rutherford 5 and 6: 79%) from 405 patients with CLI due to isolated BTK lesions 
who underwent EVT with angioplasty alone were studied. Study endpoints were AFS and freedom from MALE+POD. These were analyzed out to 5 years 
using Kaplan-Meier analysis and log-rank test. A Cox proportional hazards model was used to assess independent predictors of outcomes and to risk 
stratify each endpoint.
Results: Notable baseline characteristics included patient age (71±11yrs), diabetes mellitus (69%, 280/405), and end stage renal disease (ESRD) 
on dialysis (60%, 242/405). Mean follow-up time was 18±15 months. AFS was 63%, 45% and 33% at 1, 3, and 5 years, respectively. Predictors for 
AFS were CRP>5 (hazard ratio [HR], 3.77; 95% confidence interval [CI], 1.94-7.33; P<0.001) and non-ambulatory status (HR, 1.75; 95% CI, 1.13-
2.76; P=0.016) and heart failure (HR, 1.60; 95% CI, 1.02-2.53; P=0.042). Freedom from MALE+POD was 71%, 61% and 59% at 1, 3, and 5 years, 
respectively. Predictors for MALE+POD were CRP>5 (HR, 2.43; 95% CI, 1.37-4.30; P=0.002) and Age>80 (HR, 0.36; 95% CI, 0.18-0.73; P=0.005) 
and non-ambulatory status (HR, 1.73; 95% CI, 1.08-2.76; P=0.023) and number of below-the-ankle vessels (HR, 0.68; 95% CI, 0.47-0.98; P=0.038).
Conclusions: Long-term AFS and MALE+POD were acceptable after EVT for patients with CLI due to isolated BTK lesion.
